Full-Time

Director – Leadership and Culture Learning Partner

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Human Resources
People & HR
Required Skills
Management
Requirements
  • Bachelor’s Degree or equivalent combination of education and experience
  • Minimum 10+ years of relevant experience
  • Proven track record of designing and implementing successful leadership development programs in a fast-paced, innovative environment.
  • Strong strategic planning and execution skills, with the ability to translate business needs into effective learning solutions.
  • Excellent collaboration and partnership skills
  • Strong project management, analytical, and evaluation skills.
  • Practical knowledge of learning operations, including portfolio execution, vendor management, learning technologies, and learning evaluation
  • Learning facilitation skills
Responsibilities
  • Develop and execute a comprehensive learning strategy for leadership, management, and organizational culture development that drives peak performance in alignment with Moderna’s goals and the People Platform’s vision of leadership excellence. Your learning portfolio will include everything from onboarding to senior executive development.
  • Develop, and continuously improve learning programs, utilizing the latest in learning science and technology to maximize effectiveness and engagement.
  • On occasion, facilitate or teach learning programs in partnership with internal and external leaders and SMEs
  • Act as a strategic partner to the People Platform team, ensuring that learning programs support the development of desired leadership competencies and management practices. Advise Functional Learning Business Partners on adapting programs for their functions
  • Integrate leadership and management learning programs within the broader talent management strategy to support succession planning, high-potential development, and organizational capability building.
  • Establish metrics and evaluation processes to assess the effectiveness of leadership and management learning, making data-driven decisions to enhance program impact.
  • Stay abreast of trends, research, and innovations in leadership and management development, applying best practices and exploring new methodologies to keep Moderna at the forefront of leadership excellence.
  • Manage relationships with external vendors and consultants to support program delivery, ensuring high-quality content and delivery standards. Delegate certain learning delivery tasks—such as enrollment planning and event management—to our small internal execution team while retaining accountability for results.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to leverage the unique properties of mRNA to improve patient outcomes and create a new category of effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Opening a new vaccine facility in Victoria enhances manufacturing capabilities.
  • Strategic investment in China boosts Moderna's presence in the Asian market.
  • Collaboration with Carisma Therapeutics could lead to breakthroughs in autoimmune treatments.

What critics are saying

  • Potential removal from Nasdaq 100 could impact investor perception.
  • Reticence in Hong Kong for Covid-19 jab indicates market penetration challenges.
  • Expansion into China may expose Moderna to geopolitical and regulatory risks.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for innovative medical treatments.
  • The company has a strong focus on developing vaccines for infectious diseases.
  • Moderna's mRNA platform enables rapid development of therapeutics and vaccines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE